Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 History  





2 Organization  



2.1  Membership  



2.1.1  Current members  





2.1.2  Former members  







2.2  Health Research Foundation  







3 References  














Innovative Medicines Canada







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Innovative Medicines Canada
FormationApril 1914; 110 years ago (1914-04)
HeadquartersOttawa, Ontario

President

Cole Pinnow
AffiliationsHealth Research Foundation
Websitehttps://innovativemedicines.ca/

Formerly called

Canadian Association of Manufacturers of Medicinal and Toilet Products (1914-1915)

Canadian Pharmaceutical Manufacturers Association (1915-1965)

Pharmaceutical Manufacturers Association of Canada (1965-1999)

Canada’s Research-Based Pharmaceutical Companies (1999-2016)

Innovative Medicines Canada (IMC) is a national association of pharmaceutical companies that represents the interests of the research-based pharmaceutical industry in Canada. Its membership includes biopharmaceutical companies, vaccine developers, and manufacturers of medical devices, and works with government agencies, insurance companies, healthcare professionals and other stakeholders in the regulation and promotion of medicines.[1][2]

IMC is headquartered in Ottawa, Ontario, and its board of directors is chaired by Pfizer Canada President Cole Pinnow.[3][4]

History[edit]

In April 1914, representatives from ten Canadian pharmaceutical and personal hygiene companies founded the Canadian Association of Manufacturers of Medicinal and Toilet Products.[5] The organization initially accepted individuals as members as opposed to companies themselves, with the original membership including leading figures from Frederick Stearns & Company, F.W. Horner, John Wyeth & Bros., Toronto Pharmacal, Parke, Davis & Co., Seely Manufacturing, Charles E. Frosst & Co., National Drug & Chemical Co., Lyman Bros. & Co., and Henry K. Wampole & Co.

In 1915, the organization changed its name to the Canadian Pharmaceutical Manufacturers Association, and by 1924 had established separate divisions for pharmaceuticals, perfumes and physician supplies.[6] The name was changed again in 1965 to the Pharmaceutical Manufacturers Association of Canada (PMAC), and to Canada’s Research-Based Pharmaceutical Companies (Rx&D) in 1999.[7] Finally, in 2016, the name Innovative Medicines Canada was introduced.[8]

In 2020, IMC contested price regulation reforms introduced by Government of Canada that would require increased financial reporting from pharmaceutical companies, while simultaneously reducing reporting requirements related to veterinary medicines, over-the-counter drugs and most generic medicines.[9][10]

Cole Pinnow, President of Pfizer Canada, was announced as the new chair of IMC's Board of Directors in November 2021.[3] In April 2022, IMC implemented a revised Code of Ethical Practices that included significant changes aimed to reduce the promotional nature of its educational programs.[11]

Organization[edit]

IMC is represented on the board of directors for the Pharmaceutical Advertising Advisory Board (PAAB) by Crawford Wright, head of compliance at EMD Serono.[12]

Membership[edit]

Current members[edit]

Members of IMC as of May 2022 include:[13]

  • Amgen
  • Amicus Therapeutics
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • BioCryst Pharmaceuticals
  • BioVectra
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Brunel
  • Ceapro
  • Charles River Laboratories
  • Council for Continuing Pharmaceutical Education
  • Eli Lilly and Company
  • Elvium Life Sciences
  • EMD Serono
  • Emergent BioSolutions
  • Endoceutics
  • Gilead Sciences
  • GlaxoSmithKline
  • Horizon Therapeutics
  • Incyte
  • Ipsen
  • Janssen
  • JN Nova
  • Knight Therapeutics
  • Leo Pharma
  • Lundbeck
  • Medicago
  • Merck
  • Nordic Pharma
  • Novartis
  • Novo Nordisk
  • Novocure
  • Otsuka Pharmaceutical
  • Paladin Labs
  • Pfizer
  • Roche
  • Ropack Pharma Solutions
  • Sanofi
  • Santen Pharmaceutical
  • Servier
  • Sobi
  • Sunovion
  • Takeda Pharmaceutical Company
  • Theratechnologies
  • Valeo Pharma
  • Vantage Biotrials
  • Former members[edit]

    Former members include Actelion, Almirall, Eisai, Ferring Pharmaceuticals, Genome Canada, ProMetic Life Sciences, Purdue Pharma, Sanofi Pasteur, Shire, and Therapure BioPharma.[14][15][16]

    Health Research Foundation[edit]

    Canada’s Health Research Foundation (HRF) is a non-profit organization that invests in health research in Canadian academic centres, and promotes the benefits and values of research-driven health innovation in Canada. Innovative Medicines Canada members pay an annual contribution of $1 million to the Foundation.[17]

    References[edit]

    1. ^ Innovative Medicines Canada (2021-08-06). "Written submission for the pre-budget consultations in advance of the upcoming 2022 federal budget" (PDF). House of Commons of Canada. Archived (PDF) from the original on 2022-03-16. Retrieved 2022-08-28.
  • ^ "Innovative Medicines Canada". Research Canada. Archived from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ a b Brophy, Erin (2021-11-23). "Innovative Medicines Canada Introduces New Chair, Cole Pinnow". Life Sciences British Columbia. Archived from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ "Cole Pinnow Biography" (PDF). Canadian Chamber of Commerce. April 2021. Archived (PDF) from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ "About". Innovative Medicines Canada. Archived from the original on 2022-06-19. Retrieved 2022-08-28.
  • ^ Gouvernement du Canada, Services publics et Approvisionnement Canada (2019-09-30). "CANADIAN ASSOCIATION MANUFACTURERS MEDICINAL TOILET PRODUCTS [1 fiche]". TERMIUM Plus (in French). Archived from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ "Innovative Medicines Canada (IMC) updates its Code of Ethical Practices". Licks Attorneys' Compliance Blog. 2022-03-27. Archived from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ Lougheed, Tim (2017-05-01). "New Prescription". The Chemical Institute of Canada. Archived from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ Macnab, Aidan (2022-08-25). "COVID pandemic highlighted Canada's unique pharmaceutical IP protection regime: lawyer". Canadian Lawyer. Archived from the original on 2022-08-26. Retrieved 2022-08-28.
  • ^ "Innovative Medicines Canada v. Canada (Attorney General)". CanLII. 2020-06-29. Retrieved 2022-08-28.
  • ^ Vanderveken, Mark; Jospé, Dara; Saragosa, Eric (2022-02-03). "Updated Industry Code: Innovative Medicines Canada Publishes Its 2022 Code of Ethical Practices". Fasken. Archived from the original on 2022-08-30. Retrieved 2022-08-30.
  • ^ "About". Pharmaceutical Advertising Advisory Board / Conseil Consultatif de Publicité Pharmaceutique. Archived from the original on 2018-09-24. Retrieved 2022-08-28.
  • ^ "Member Companies". Innovative Medicines Canada. 2021. Archived from the original on 2022-05-31. Retrieved 2022-08-28.{{cite web}}: CS1 maint: unfit URL (link)
  • ^ Fralick, Pamela; Miller, Ronnie (May 2020). "Annual Report 2019" (PDF). IMC Annual Report. Archived (PDF) from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ Williams, Russell; Helou, John (November 2015). "Rx&D 2015 Annual Report" (PDF). Innovative Medicines Canada. Archived (PDF) from the original on 2022-01-20. Retrieved 2022-08-28.
  • ^ Campbell, Elaine; Tremblay, Michael (2017-01-01). "2016 Annual Report" (PDF). Innovative Medicines Canada. Archived (PDF) from the original on 2022-08-28. Retrieved 2022-08-28.
  • ^ "About". Health Research Foundation. Archived from the original on 2022-01-04. Retrieved 2022-08-28.{{cite web}}: CS1 maint: unfit URL (link)

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Innovative_Medicines_Canada&oldid=1208968471"

    Categories: 
    Pharmaceutical industry trade groups
    Trade associations based in Ontario
    Organizations based in Ottawa
    Organizations established in 1914
    1914 establishments in Ontario
    Hidden categories: 
    CS1 French-language sources (fr)
    CS1 maint: unfit URL
    Articles with short description
    Short description matches Wikidata
     



    This page was last edited on 19 February 2024, at 18:27 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki